StockWatch
·
Pharmaceuticals
Business Update15 May 2026, 05:11 pm

Hester Bio Corporate Presentation for FY 2025-26

AI Summary

Hester Biosciences Ltd has released its corporate presentation for FY 2025-26, as per Regulation 30 of SEBI guidelines. The presentation highlights the company's mission for better human health through healthier animals, its vision to build on a foundation of excellence, and core values including integrity, innovation, passion, discipline, and trust. Key figures mentioned include consolidated revenue of ₹3,325.99 Mn for FY 2025-26.

Key Highlights

  • Hester Biosciences releases corporate presentation for FY 2025-26.
  • Consolidated revenue for FY 2025-26 reported as ₹3,325.99 Mn.
  • Rajiv Gandhi and Priya Gandhi are key executive leaders.
  • The company has a global footprint in 35+ countries.